Alinamin Pharmaceutical Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 290

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 3

Alinamin Pharmaceutical General Information

Description

Manufacturer of pharmaceutical products based in Tokyo, Japan. The company specializes in the research and development, manufacturing and sales, thereby marketing of over-the-counter products and quasi-drugs as per their client's requirement.

Contact Information

Formerly Known As
Takeda Consumer Healthcare, Takeda Healthcare
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 23rd Floor, Tekko Building
  • 1-8-2 Marunouchi, Chiyoda-ku
  • Tokyo, 100-0005
  • Japan
+81
Primary Industry
Pharmaceuticals
Other Industries
Other Consumer Non-Durables
Vertical(s)
Corporate Office
  • 23rd Floor, Tekko Building
  • 1-8-2 Marunouchi, Chiyoda-ku
  • Tokyo, 100-0005
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alinamin Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alinamin Pharmaceutical‘s full profile, request access.

Request a free trial

Alinamin Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products based in Tokyo, Japan. The company specializes in the research and development,
Pharmaceuticals
Tokyo, Japan
290 As of 2026

Tokyo, Japan
 

Osaka, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alinamin Pharmaceutical Competitors (14)

One of Alinamin Pharmaceutical’s 14 competitors is Taisho Pharmaceutical, a Corporate Backed or Acquired company based in Tokyo, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Taisho Pharmaceutical Corporate Backed or Acquired Tokyo, Japan
Shionogi Corporation Osaka, Japan
Kobayashi Pharmaceutical Corporation Osaka, Japan
Sun Pharmaceutical Industries Corporation Mumbai, India
Taiho Pharma Corporation Tokyo, Japan
You’re viewing 5 of 14 competitors. Get the full list »

Alinamin Pharmaceutical Patents

Alinamin Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026015281-A Coating formulation Pending 17-Jul-2024
JP-2026015282-A Vitamin b12 containing solid preparation Pending 17-Jul-2024
JP-2025152294-A Demand forecast system and demand forecast program Active 28-Mar-2024
JP-2022181202-A Pharmaceutical preparation Pending 25-May-2021
JP-2022167880-A Solid preparation Pending 23-Apr-2021
To view Alinamin Pharmaceutical’s complete patent history, request access »

Alinamin Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alinamin Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alinamin Pharmaceutical‘s full profile, request access.

Request a free trial

Alinamin Pharmaceutical Investments (3)

Alinamin Pharmaceutical’s most recent deal was a Buyout/LBO with Nihon Pharmaceutical. The deal was made on 01-Jul-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nihon Pharmaceutical 01-Jul-2024 Buyout/LBO Distributors/Wholesale
Takeda Pharmaceutical Company (OTC Pharmaceutical Business in Taiwan) 01-Jan-2022 Buyout/LBO Pharmaceuticals
Yuka Holdings 01-Jan-2022 Buyout/LBO Holding Companies
To view Alinamin Pharmaceutical’s complete investments history, request access »

Alinamin Pharmaceutical Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Nihon Pharmaceutical Osaka, Japan 1946
Takeda Pharmaceutical Company (OTC Pharmaceutical Business in Taiwan) Taiwan

Alinamin Pharmaceutical FAQs

  • When was Alinamin Pharmaceutical founded?

    Alinamin Pharmaceutical was founded in 2017.

  • Where is Alinamin Pharmaceutical headquartered?

    Alinamin Pharmaceutical is headquartered in Tokyo, Japan.

  • What is the size of Alinamin Pharmaceutical?

    Alinamin Pharmaceutical has 290 total employees.

  • What industry is Alinamin Pharmaceutical in?

    Alinamin Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Alinamin Pharmaceutical a private or public company?

    Alinamin Pharmaceutical is a Private company.

  • What is the current valuation of Alinamin Pharmaceutical?

    The current valuation of Alinamin Pharmaceutical is .

  • What is Alinamin Pharmaceutical’s current revenue?

    The current revenue for Alinamin Pharmaceutical is .

  • Who are Alinamin Pharmaceutical’s investors?

    CPP Investments and MBK Partners have invested in Alinamin Pharmaceutical.

  • Who are Alinamin Pharmaceutical’s competitors?

    Taisho Pharmaceutical, Shionogi, Kobayashi Pharmaceutical, Sun Pharmaceutical Industries, and Taiho Pharma are some of the 14 competitors of Alinamin Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process